why choose us

First received: December 15, 2022

Clinical Trial: Efficacy and Safety of Ambervin® and Standard Therapy in Hospitalized Patients With COVID-19

Study Status: Completed

Recruit Status: Completed

Condition: COVID-19

Study Type: Interventional


Official Title: An Open Randomized Multicenter Comparative Study to Evaluate the Efficacy, Safety and Tolerability of the Use of Ambervin® for Intramuscular Administration and for Inhalation in Patients Hospitalized

Brief Summary: This is open-labe randomized multicenter comparative Phase III study conducted in 8 medical facilities. The objective of the study is to assess the efficacy, safety and tolerability of Ambervin for intramuscular and inhaled administration in complex therapy COVID-19 compared with the Standard of care (SOC) in hospitalized patients with moderate COVID-19.

Read more